Construction and analysis of the lncRNA-miRNA-mRNA network based on competitive endogenous RNA reveals functional genes in heart failure
暂无分享,去创建一个
Yang Zheng | Jian Wu | Maomao Zhang | Yang Zheng | Yong Sun | Rui Cao | Guohong Wang | Xianghui Zheng | Rui Cao | Maomao Zhang | Yong Sun | Jian Wu | Xianghui Zheng | Guohong Wang
[1] Paola Fuschi,et al. Long noncoding RNA dysregulation in ischemic heart failure , 2016, Journal of Translational Medicine.
[2] Dong Wang,et al. Competing endogenous RNA networks in human cancer: hypothesis, validation, and perspectives , 2016, Oncotarget.
[3] Hsien-Da Huang,et al. miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions , 2017, Nucleic Acids Res..
[4] I. Ng,et al. Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications , 2018, Nature Reviews Gastroenterology & Hepatology.
[5] Chun-mei Li,et al. LncRNA TUG1 serves an important role in hypoxia-induced myocardial cell injury by regulating the miR-145-5p-Binp3 axis , 2017, Molecular medicine reports.
[6] E. Braunwald. The war against heart failure: the Lancet lecture , 2015, The Lancet.
[7] P. Tontonoz,et al. Long Noncoding RNA Discovery in Cardiovascular Disease: Decoding Form to Function , 2018, Circulation research.
[8] J. Carroll,et al. Network analysis of SRC-1 reveals a novel transcription factor hub which regulates endocrine resistant breast cancer , 2018, Oncogene.
[9] Pei Ma,et al. Long Noncoding RNA LINC01234 Functions as a Competing Endogenous RNA to Regulate CBFB Expression by Sponging miR-204-5p in Gastric Cancer , 2018, Clinical Cancer Research.
[10] J. Bauersachs,et al. Immune mechanisms in heart failure , 2017, European journal of heart failure.
[11] Jian Wu,et al. Identification of key genes and pathways in regulating immune-induced diseases of dendritic cells by bioinformatic analysis , 2018, Molecular medicine reports.
[12] D. Bartel,et al. lincRNAs: Genomics, Evolution, and Mechanisms , 2013, Cell.
[13] S. Solomon,et al. Improving Heart Failure Therapeutics Development in the United States: The Heart Failure Collaboratory. , 2018, Journal of the American College of Cardiology.
[14] Panayiotis Tsanakas,et al. DIANA-LncBase v2: indexing microRNA targets on non-coding transcripts , 2015, Nucleic Acids Res..
[15] S. Zhuang,et al. HOTAIR functions as a competing endogenous RNA to regulate PTEN expression by inhibiting miR-19 in cardiac hypertrophy , 2017, Molecular and Cellular Biochemistry.
[16] Y. Tham,et al. Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets , 2015, Archives of Toxicology.
[17] C. Murray,et al. The Global Burden of Ischemic Heart Disease in 1990 and 2010: The Global Burden of Disease 2010 Study , 2014, Circulation.
[18] Sean R. Davis,et al. NCBI GEO: archive for functional genomics data sets—update , 2012, Nucleic Acids Res..
[19] M. Aronovitz,et al. Th1 effector T cells selectively orchestrate cardiac fibrosis in nonischemic heart failure , 2017, The Journal of experimental medicine.
[20] P. Shi,et al. LncRNA GAS5 controls cardiac fibroblast activation and fibrosis by targeting miR-21 via PTEN/MMP-2 signaling pathway. , 2017, Toxicology.
[21] N. Smart,et al. Effect of aerobic and resistance training on inflammatory markers in heart failure patients: systematic review and meta-analysis , 2018, Heart Failure Reviews.
[22] Shuwen Han,et al. Competitive endogenous RNA in colorectal cancer: A systematic review. , 2018, Gene.
[23] Lu Gao,et al. Circulating Long Noncoding RNA HOTAIR is an Essential Mediator of Acute Myocardial Infarction , 2017, Cellular Physiology and Biochemistry.
[24] P. Little,et al. Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics. , 2019, Pharmacology & therapeutics.
[25] M. Maurer,et al. Pathophysiology of Heart Failure , 2007 .
[26] Yun Xiao,et al. Dysregulated long intergenic non-coding RNA modules contribute to heart failure , 2016, Oncotarget.
[27] Hui Jiang,et al. Reconstruction and analysis of the lncRNA-miRNA-mRNA network based on competitive endogenous RNA reveal functional lncRNAs in rheumatoid arthritis. , 2017, Molecular bioSystems.
[28] Gerasimos S Filippatos,et al. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. , 2017, Journal of cardiac failure.
[29] P. Ponikowski,et al. Signature of circulating microRNAs in patients with acute heart failure , 2016, European journal of heart failure.
[30] Eugene Berezikov,et al. Rodent heart failure models do not reflect the human circulating microRNA signature in heart failure , 2017, PloS one.
[31] S. Epelman,et al. Chronic Heart Failure and Inflammation: What Do We Really Know? , 2016, Circulation research.
[32] J. Fildes,et al. The immune system and chronic heart failure: is the heart in control? , 2009, Journal of the American College of Cardiology.
[33] Wang Ma,et al. ceRNA in cancer: possible functions and clinical implications , 2015, Journal of Medical Genetics.
[34] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.
[35] Lan V. Zhang,et al. Evidence for dynamically organized modularity in the yeast protein–protein interaction network , 2004, Nature.
[36] P. Pandolfi,et al. A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language? , 2011, Cell.
[37] Dandan Liang,et al. miRNA-940 reduction contributes to human Tetralogy of Fallot development , 2014, Journal of cellular and molecular medicine.
[39] Howard Y. Chang,et al. Molecular mechanisms of long noncoding RNAs. , 2011, Molecular cell.
[40] J. Hulot,et al. Gene therapy for the treatment of heart failure: promise postponed. , 2016, European heart journal.
[41] Saumya Das,et al. Circulating miR-21, miR-378, and miR-940 increase in response to an acute exhaustive exercise in chronic heart failure patients , 2016, Oncotarget.
[42] Gerasimos S Filippatos,et al. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. , 2017, Journal of the American College of Cardiology.
[43] Hulun Li,et al. Inhibition of MicroRNA let-7i Depresses Maturation and Functional State of Dendritic Cells in Response to Lipopolysaccharide Stimulation via Targeting Suppressor of Cytokine Signaling 1 , 2011, The Journal of Immunology.
[44] C. Bearzi,et al. Increased BACE1-AS long noncoding RNA and &bgr;-amyloid levels in heart failure , 2017, Cardiovascular research.
[45] Z. Papp,et al. Causes and pathophysiology of heart failure with preserved ejection fraction. , 2014, Heart failure clinics.